Hilltop Holdings Inc. Acquires 20,291 Shares of CVS Health Co. (NYSE:CVS)

Hilltop Holdings Inc. grew its stake in shares of CVS Health Co. (NYSE:CVSFree Report) by 109.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,909 shares of the pharmacy operator’s stock after acquiring an additional 20,291 shares during the quarter. Hilltop Holdings Inc.’s holdings in CVS Health were worth $3,072,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. SOA Wealth Advisors LLC. lifted its position in shares of CVS Health by 4.9% during the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock valued at $226,000 after buying an additional 133 shares in the last quarter. Apella Capital LLC grew its position in shares of CVS Health by 4.2% during the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after purchasing an additional 136 shares in the last quarter. Prairie Sky Financial Group LLC grew its holdings in CVS Health by 4.1% during the 4th quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock valued at $285,000 after buying an additional 141 shares in the last quarter. WealthShield Partners LLC increased its holdings in CVS Health by 3.2% in the 4th quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock valued at $355,000 after acquiring an additional 141 shares during the last quarter. Finally, Sugarloaf Wealth Management LLC lifted its position in shares of CVS Health by 9.5% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after buying an additional 142 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling

In other news, Director Edward J. Ludwig acquired 1,000 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were bought at an average cost of $53.88 per share, with a total value of $53,880.00. Following the transaction, the director now owns 21,630 shares in the company, valued at approximately $1,165,424.40. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.24% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Royal Bank of Canada dropped their target price on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. StockNews.com downgraded CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Barclays cut their price objective on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 2nd. TD Cowen lowered CVS Health from a “buy” rating to a “hold” rating and decreased their price objective for the company from $99.00 to $59.00 in a report on Tuesday, May 7th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $66.00 price objective (down from $90.00) on shares of CVS Health in a research report on Thursday, May 2nd. Nine investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $76.75.

View Our Latest Report on CVS

CVS Health Trading Down 0.2 %

Shares of CVS Health stock traded down $0.11 on Friday, reaching $55.54. The company had a trading volume of 11,725,739 shares, compared to its average volume of 17,230,286. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. The firm has a market cap of $69.72 billion, a PE ratio of 9.76, a PEG ratio of 0.53 and a beta of 0.56. The firm’s 50 day moving average price is $67.13 and its two-hundred day moving average price is $71.94. CVS Health Co. has a 52-week low of $53.70 and a 52-week high of $83.25.

CVS Health (NYSE:CVSGet Free Report) last released its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the company earned $2.20 earnings per share. Sell-side analysts predict that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were issued a $0.665 dividend. The ex-dividend date was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.79%. CVS Health’s dividend payout ratio (DPR) is 46.75%.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Further Reading

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.